Clinical Trials Browser

Phase 4 × Adenocarcinoma × Docetaxel × Clear all

NCT01665417 2017-02-08

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma